Philadelphia, PA, United States of America

Takahiro Sato

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Janssen Biotech, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takahiro Sato. Retrieved from https://idiyas.com/inventor/takahiro-sato-3r30xee6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Takahiro Sato

Introduction

Takahiro Sato is an accomplished inventor based in Philadelphia, PA. He has made significant contributions to the field of medical research, particularly in the area of inflammatory bowel disease. His work is recognized for its potential to improve therapeutic responses for patients suffering from this condition.

Latest Patents

Takahiro Sato holds a patent titled "Methods and Compositions for Prediction of Response to a Therapy of an Inflammatory Bowel Disease." This patent represents a crucial advancement in understanding how to tailor treatments for individuals based on their specific responses to therapies.

Career Highlights

Sato is currently employed at Janssen Biotech, Inc., where he continues to innovate and develop new solutions in the medical field. His work at Janssen has positioned him as a key player in the research and development of therapies aimed at improving patient outcomes.

Collaborations

Takahiro has collaborated with notable colleagues, including Frederic Baribaud and Carrie Brodmerkel. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Takahiro Sato's contributions to medical research and his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to impact the field positively, paving the way for advancements in treatment for inflammatory bowel disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…